We serve Chemical Name:Hydroxypropyl-β-cyclodextrin CAS:128446-35-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Hydroxypropyl-β-cyclodextrin
CAS.NO:128446-35-5
Synonyms:(2-Hydroxypropyl)-Beta-Cyclodextrin;EINECS 420-920-1;MFCD00069372;Hydroxypropyl-beta-cyclodextrin;(2-HYDROXYPROPYL)-β-CYCLODEXTRIN;(2-Hydroxypropyl)-Beta-Cyclodextri;Hydroxypropyl-β-cyclodextrin
Molecular Formula:C63H112O42
Molecular Weight:1541.538
HS Code:
Physical and Chemical Properties:
Melting point:278ºC (dec.)
Boiling point:1521.9±60.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.545
PSA:618.66000
Exact Mass:1540.662842
LogP:-6.23
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like (2-Hydroxypropyl)-Beta-Cyclodextrin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hydroxypropyl-β-cyclodextrin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2-Hydroxypropyl)-Beta-Cyclodextri Use and application,MFCD00069372 technical grade,usp/ep/jp grade.
Related News: The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Hydroxypropyl-β-cyclodextrin manufacturer Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete. Hydroxypropyl-β-cyclodextrin supplier Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. Hydroxypropyl-β-cyclodextrin vendor An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. Hydroxypropyl-β-cyclodextrin factory Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete.
